Implementation Challenges of Universal Suicide Risk Screening in Adult Patients in General Medical and Surgical Settings
The authors share evidence-based guidance for patient safety that minimizes suicide risk in medical settings.
The authors share evidence-based guidance for patient safety that minimizes suicide risk in medical settings.
The extension trial aims to address the cognitive impairment often observed in schizophrenia.
This 2024 APA Annual Meeting poster documented the abuse potential of benzodiazepines and tapering challenges.
Poster aims to improve awareness of the potential risk of suicidal ideation in patients taking semaglutide.
Poster at the 2024 APA Annual Meeting explores link between MDD, atopic dermatitis, psoriasis, and inflammation.
This 2024 APA Annual Meeting poster estimated the prevalence of tardive dyskinesia in antipsychotic users in the US, and found rates ranging from 94.1-127.4 per…
This 2024 APA Annual Meeting poster investigated the relationship between antiobesity agents like semaglutide and depression.
Are individuals with bipolar disorder more likely to die from unnatural causes than the general population?
This 2024 APA Annual Meeting poster covered a literature review on the relationship between stimulant use and failure to thrive in pediatric patients with ADHD.
What is the potential impact of social media overuse and mental health crises in young patients?
Petros Levounis, MD, MA, talks addiction, buprenorphine, his year as president of the APA, and more at the 2024 Annual Meeting.